Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban pharmacokinetics before and during tamoxifen in women with breast cancer
NL-OMON49411Active, not recruiting
- Sponsor
- Tergooi MC
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of edoxaban and tamoxifen in venous thromboembolism (VTE) and breast cancer, sponsored by Tergooi MC. Started Dec 2019; status: active, not recruiting.
02
Drugs
edoxabantamoxifen
03
Conditions
venous thromboembolism (VTE)breast cancer
Beyond the preview
Go deeper on NL-OMON49411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49411.